Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Leukemia, Myelomonocytic, Chronic × regorafenib × 90 days × Clear all

Sponsor

Conditions

Colorectal Neoplasms 15 Carcinoma, Hepatocellular 4 Sarcoma, Ewing 3 Sarcoma 2 Glioblastoma 2 Esophageal Neoplasms 2 Colonic Neoplasms 2 Uterine Cervical Neoplasms 1 Stomach Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Solid Malignant Tumors 1 Small Cell Lung Carcinoma 1 Rectal Neoplasms 1 Patient Compliance 1 Pathologic Complete Response 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Osteosarcoma 1 Neoplasms 1 Neoplasm Metastasis 1 Multiple Myeloma 1 Melanoma 1 MSI-H Colorectal Cancer 1 Lymphoma, Non-Hodgkin 1 Liver Neoplasms 1 Liver Metastasis Colon Cancer 1 Leukemia, Myeloid, Acute 1 Leiomyosarcoma 1 Histiocytoma, Malignant Fibrous 1 Hemangiosarcoma 1 HER2-positive Colorectal Cancer 1

Interventions

Azacitidine 14 venetoclax 12 Specimen Handling 7 Decitabine 7 Biopsy 7 fludarabine 6 Injections 6 decitabine and cedazuridine drug combination 5 Stem Cell Transplantation 5 Cytarabine 5 Cyclophosphamide 5 fludarabine phosphate 4 Whole-Body Irradiation 4 Tacrolimus 3 Mycophenolic Acid 3 Hematopoietic Stem Cell Transplantation 3 Busulfan 3 sabatolimab 2 ruxolitinib 2 olutasidenib 2 enasidenib 2 cedazuridine 2 axatilimab 2 X-Rays 2 Vorinostat 2 Peripheral Blood Stem Cell Transplantation 2 Magnetic Resonance Spectroscopy 2 Lenalidomide 2 Idarubicin 2 Granulocyte Colony-Stimulating Factor 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡